colchicine

(redirected from Colcrys)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Colcrys: colchicine

col·chi·cine

 (kŏl′chĭ-sēn′, kŏl′kĭ-)
n.
A poisonous alkaloid, C22H25NO6, that is obtained from the autumn crocus and inhibits microtubule formation. It is used in medicine to treat gout and in plant breeding to produce polyploid plants.

colchicine

(ˈkɒltʃɪˌsiːn; -sɪn; ˈkɒlkɪ-)
n
(Biochemistry) a pale-yellow crystalline alkaloid extracted from seeds or corms of the autumn crocus. It is used in the treatment of gout and to create polyploid plants by inhibiting chromosome separation during meiosis. Formula: C22H25NO6
[C19: from colchicum + -ine2]

col•chi•cine

(ˈkɒl tʃəˌsin, -sɪn, ˈkɒl kə-)

n.
a pale yellow, crystalline alkaloid, C22H25NO6, the active principle of colchicum.
[1850–55]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.colchicine - an analgesic drug derived from the saffron plant and used to treat gout
analgesic, anodyne, pain pill, painkiller - a medicine used to relieve pain
Translations
colchicine

colchicine

n colchicina
References in periodicals archive ?
Clinical trials of Colcrys showed that lower doses were as effective as higher doses and produced fewer side effects.
The FDA's approval of Colcrys came with exclusive marketing rights for gout for 3 years and for familial Mediterranean fever for 7 years.
It was reported yesterday that the agreement has been signed for the distribution rights of Colchicine Tablets, USP, the Authorised Generic version of Colcrys (colchicine, USP) Tablets in the United States.
Colcrys is part of Takeda s gout treatment portfolio, and was launched commercially in the U.
11 April 2012 - Takeda America Holdings Inc, a unit of Japana[euro](tm)s Takeda Pharmaceutical Company Ltd (TYO:4502), will take over US URL Pharma Inc, the maker of the Colcrys drug used to treat and prevent gout flares, the parties said on Wednesday.
Currently, acute gout can be treated using NSAIDs, corticosteroids and Colcrys, while doctors can prescribe uricosurics sulphinpyrazone, benzbromarone or xanthine oxidase inhibitors to treat chronic gout.
As a result of this partnership, Colchicine Tablets, USP will be the only colchicine product on the market that is therapeutically equivalent and automatically substitutable for prescriptions written for Colcrys Tablets, indicated for the prophylaxis and treatment of acute gout flares in adults, and the treatment of familial Mediterranean fever (FMF) in adults and children age four or older.
According to the contract, Takeda Pharmaceuticals USA will retain Colcrys ownership rights and will be responsible to market and promote Colcrys, a prescription medicine used in adults to treat flares linked with gout.
My patient was released from the hospital on Colcrys (colchicine) twice a day, but she found that she needed three pills a day to control her arthritis and her family physician was worried about her taking such a high dose of the medication.
mln9708 (ixazomib) multiple myeloma TOP SELLING DRUGS DRUG INDICATION 2013 SALES (+/- %) Candesartan hypertension $1,507 -14% Leuprorelin prostatic cancer $1,206 8% Pioglitazone type 2 diabetes $1,196 37% Lansoproazole peptic ulcers $1,148 8% Pantoprazole GERD $1,050 25% Velcade multiple myeloma $924 73% Colcrys gout $506 18% Dexilant GERD $486 4% Nesina type 2 diabetes $389 5% Uloric high uric acid $263 92% Amitzia IBS $253 3% Calcium hypertension $185 15% Adcetris Hodgkin lymphoma $136 5%
Pillinger disclosed ties with Savient and Takeda, which markets colchicine as Colcrys.